|
|
| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Post-Transplant, Parvovirus B19 DNA, Real-Time PCR, Plasma
Test Code18068
CPT Codes
87799
Preferred Specimen
1 mL plasma collected in an EDTA (lavender-top) tube
Minimum Volume
0.5 mL
Instructions
For Shipper collection please see detailed instructions in Test Resources
Transport Temperature
Refrigerated (cold packs)
Specimen Stability
Room temperature: 48 hours
Refrigerated: 7 days
Frozen: 30 days
Refrigerated: 7 days
Frozen: 30 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Samples collected in sodium or lithium heparin
Methodology
Real-Time Polymerase Chain Reaction
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
Monday-Sunday Morning
Report available: Next Day
Report available: Next Day
Reference Range
| Parvovirus B19 DNA, QN PCR | Not Detected (copies/mL) |
| Parvovirus B19 DNA, QN PCR | Not Detected (Log copies/mL) |
Clinical Significance
Parvovirus B19 infection has a wide variety of disease manifestations, including Fifth disease, transient aplastic crisis, persistent anemia and congenital hydrops fetalis. Quantification of parvovirus B19 genomic DNA is based upon Real-Time PCR amplification and detection. Reportable range is 100 to 100,000,000 copies/mL (2.00 to 8.00 Log copies/mL).
